Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeloda and Avastin with Irinotecan or Oxaliplatin in Metastatic Colorectal Cancer
NCT00642603Phase 2Terminated
- Sponsor
- Roche
- Start
- May 2008
- Primary completion
- Mar 2009
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, bevacizumab in colorectal cancer (CRC), sponsored by Roche. Started May 2008; status: terminated.
02
Drugs
capecitabinebevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00642603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642603.